The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective phase 1 study assessing feasibility of IMRT and IGART to deliver simultaneous integrated high-dose tumor boost (up to 70 Gy) for the radical treatment of localized muscle-invasive bladder cancer.
 
Shaista Hafeez
No Relationships to Disclose
 
Karole Warren-Oseni
No Relationships to Disclose
 
Helen McNair
No Relationships to Disclose
 
Vibeke Hansen
No Relationships to Disclose
 
Fiona McDonald
No Relationships to Disclose
 
Susan Lalondrelle
No Relationships to Disclose
 
Alan Thompson
No Relationships to Disclose
 
Pardeep Kumar
No Relationships to Disclose
 
Victoria Harris
No Relationships to Disclose
 
Melissa Tan
Travel, Accommodations, Expenses - Astellas Pharma; Roche/Genentech
 
Kabir Mohammed
No Relationships to Disclose
 
Karen Thomas
No Relationships to Disclose
 
Kelly Jones
No Relationships to Disclose
 
David Paul Dearnaley
No Relationships to Disclose
 
Alan Horwich
No Relationships to Disclose
 
Robert Anthony Huddart
Leadership - Cancer clinic london Limited liability partnership
Honoraria - Janssen Oncology
Speakers' Bureau - AstraZeneca; Pierre Fabre
Research Funding - Active Biotech; Ipsen
Travel, Accommodations, Expenses - Janssen Oncology